1-17 of 17
Bertrand Joly
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

18-Months Follow-up of the Trial of Imatinib after Ponatinib Induction (TIPI) in the Front-Line Treatment of Chronic Phase (CP) Chronic Myeloid Leukemia (CML) Setting

Franck E. Nicolini, Aude Charbonnier, Martine Escoffre-Barbe, Eric Jourdan, Gabrielle Roth-Guepin, Marc G. Berger, Shanti Ame, Marion Simonet, Hyacinthe A Johnson-Ansah, Viviane Dubruille, Amandine Charbonnier, Philippe Rousselot, Corentin Orvain, Bertrand Joly, Jean-Christophe Ianotto, Emilie Cayssials, Mathieu Meunier, Anne Parry, Valerie Coiteux, Laurence Legros, Hacene Zerazhi, Gabriel Etienne, Philippe Quittet, Ollivier Legrand, Amelie Penot, Lydia Roy, Charlotte Doublet, Stéphane Morisset, Romaine Mayet, Gwenaëlle Garin, Stéphanie Dulucq, Françoise Huguet
Journal: Blood
Blood (2024) 144 (Supplement 1): 478.
https://doi.org/10.1182/blood-2024-198903
Published: 2024
Journal Articles

Verlen, “Very Elderly Rituximab Associated to Lenalidomide - Tafasitamab Combination in Frontline DLBCL Patients”, a Phase II Open-Label Study Evaluating Efficacy of Lenalinomide and Tafasitamab Combination Associated to Rituximab in Frontline Diffuse Large B-Cell Lymphoma Patients of 80 y/o or Older from the Lysa Group

Benoit Tessoulin, Julien Depaus, Pierre Feugier, Ludovic Fouillet, Julie Abraham, Sandy Amorin, Fabrice Jardin, Franck Morschhauser, Catherine Thieblemont, François-Xavier Gros, Bertrand Joly, Hacene Zerazhi, Sophie Bernard, Adrien Chauchet, Stéphane Vigouroux, Christophe Bonnet, Sarah Bailly, Steven Le Gouill
Journal: Blood
Blood (2023) 142 (Supplement 1): 3094.
https://doi.org/10.1182/blood-2023-173265
Published: 2023
Journal Articles

T rial of Imatinib after Ponatinib Induction (TIPI) in the Front-Line Treatment of Chronic Phase (CP) Chronic Myeloid Leukemia (CML) Setting. Report of the First Therapeutic Sequence

Franck E. Nicolini, Aude Charbonnier, Martine Escoffre-Barbe, Eric Jourdan, Gabrielle Roth-Guepin, Marc G. Berger, Shanti Amé, Marion Simonet, Hyacinthe A. Johnson-Ansah, Viviane Dubruille, Amandine Charbonnier, Philippe Rousselot, Corentin Orvain, Bertrand Joly, Jean-Christophe Ianotto, Emilie Cayssials, Mathieu Meunier, Anne Parry, Valerie Coiteux, Laurence Legros, Hacene Zerazhi, Gabriel Etienne, Philippe Quittet, Ollivier Legrand, Amelie Penot, Lydia Roy, Ludovic Fouillet, Stéphane Morisset, Isabelle Tigaud, Romaine Mayet, Gwenaëlle Garin, Jérôme Guitton, Stéphanie Dulucq, Françoise Huguet
Journal: Blood
Blood (2023) 142 (Supplement 1): 445.
https://doi.org/10.1182/blood-2023-181571
Published: 2023
Journal Articles

PET-Guided Strategy Improves the Safety of Beacopp-Based Treatment in Advanced Hodgkin Lymphoma: Prolonged Follow-up of the Lysa Ahl 2011 Phase 3 Study

Olivier Casasnovas, MD, Judith Racape, MD, Julie Dechene, Reda Bouabdallah, MD, Pauline Brice, MD, Julien Lazarovici, MD, Hervé Ghesquieres, MD PhD, Aspasia Stamatoulas Bastard, MD, Jehan Dupuis, MD, Anne-Claire Gac, MD, Thomas Gastinne, MD, Bertrand Joly, MD, Krimo Bouabdallah, MD, Emmanuelle Nicolas-Virelizier, MD, Pierre Feugier, MD, Franck Morschhauser, MD PhD, Marc André, MD, Alina Berriolo-Riedinger, MD, Veronique Edeline, MD, Clémentine Joubert, PhD, Michel Meignan, MD, Isabelle Demeestere, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 23–24.
https://doi.org/10.1182/blood-2020-136056
Published: 2020
Journal Articles

Treatment of Myeloma Cast Nephropathy (MCN): A Randomized Trial Comparing Intensive Haemodialysis (HD) with High Cut-Off (HCO) or Standard High-Flux Dialyzer in Patients Receiving a Bortezomib-Based Regimen (the MYRE Study, by the Intergroupe Francophone du Myélome (IFM) and the French Society of Nephrology (SFNDT))

Frank Bridoux, MD PhD, Brigitte Pegourie, MD, Karine Augeul-Meunier, MD, Bruno Royer, MD, Bertrand Joly, MD, Thierry Lamy, MD PhD, Brigitte Kolb, Lofti Benboubker, Bertrand Arnulf, MD, Arnaud Jaccard, MD PhD, Sylvie Chevret, Jean-Paul Fermand, MD
Journal: Blood
Blood (2016) 128 (22): 978.
https://doi.org/10.1182/blood.V128.22.978.978
Published: 2016
Journal Articles

Randomized Phase III Study Comparing an Early PET Driven Treatment De-Escalation to a Not PET-Monitored Strategy in Patients with Advanced Stages Hodgkin Lymphoma: Interim Analysis of the AHL2011 Lysa Study

Olivier Casasnovas, MD, Pauline Brice, MD, Reda Bouabdallah, MD, Gilles A. Salles, MD PhD, Aspasia Stamatoullas, MD, Jehan Dupuis, MD, Oumedaly Reman, MD, Thomas Gastinne, MD, Bertrand Joly, MD, Krimo Bouabdallah, MD, Emmanuelle Nicolas-Virelizier, MD, Serge Bologna, MD, Franck Morschhauser, MD, Richard Delarue, MD, Hassan Farhat, MD, Philippe Quittet, MD, Alina Berriolo-Riedinger, MD, Adrian Tempescul, Véronique Edeline, MD, Herve Maisonneuve, MD, Jean Claude Eisenmann, MD, Alexandra Traverse-Glehen, Marc Andre, MD, Nicolas Mounier, MD PhD, Michel Meignan, MD PhD, Christophe Fermé, MD
Journal: Blood
Blood (2015) 126 (23): 577.
https://doi.org/10.1182/blood.V126.23.577.577
Published: 2015
Journal Articles

Bendamustine Treatment in Refractory or Relapsed T Cell Lymphomas: A Retrospective Multicenter Study

Emilie Reboursiere, Fabien Le Bras, Franck Morschhauser, MD, Emmanuel Gyan, MD PhD, Aline Clavert, MD, Sandra Malak, David Sibon, MD, Marion Damge, Claude Gardin, Luc-Matthieu Fornecker, Reda Garidi, Sabine Tricot, Roch Houot, Bertrand Joly, MD, Wajed Abarah, MD, Bachra Choufi, MD, Anne-dominique Pham, Sylvain P Chantepie, MD, Christophe Fruchart, MD, Anne-Claire Gac, Catherine Ollivier, Emilie Marin, Violaine Safar, Anne Parcelier, MD, Herve Maisonneuve, MD, Emmanuel Bachy, Guillaume Cartron, MD PhD, Arnaud Jaccard, MD PhD, Olivier Tournilhac, Cedric Rossi, MD, Aurore Perrot, Jean-Alain Martignoles, Herve Tilly, MD PhD, Gandhi Damaj, MD PhD
Journal: Blood
Blood (2015) 126 (23): 1505.
https://doi.org/10.1182/blood.V126.23.1505.1505
Published: 2015
Journal Articles

Frontline Therapy with the Ribvd Regimen Elicits High Clinical and Molecular Response Rates and Long PFS in Elderly Patients Mantle Cell Lymphoma (MCL); Final Results of a Prospective Phase II Trial By the Lysa Group

Remy Gressin, MD, Mary Callanan, MD PhD, Nicolas Daguindau, MD, Adrian Tempescul, MD, Sylvain Carras, Marie Pierre Moles, MD, Guillaume Cartron, MD, Roch Houot, MD PhD, Caroline Dartigeas, MD, Jean Michel Pignon, MD, Selim Corm, MD PhD, Anne Banos, MD, Christiane Mounier, MD, Jehan Dupuis, MD, Margareth Macro, MD, Joel Fleury, MD, Fabrice Jardin, MD PhD, Lionel Karlin, Pierre Feugier, MD PhD, Luc Matthieu Fornecker, MD, Cecile Chabrot, Veronique Dorvaux, MD, Krimo Bouabdallah, MD, Sandy Amorin, MD, Reda Garidi, MD, Laurent Voillat, MD, Bertrand Joly, MD, Katell Le Dû, Nadine Morineau, Hacene Zerazhi, MD, Jean Fontan, Yazid Arkam, MD, Magda Alexis, MD, Vincent Delwail, MD, Jean Pierre Vilque, MD, Loic Ysebaert, MDPhD, Steven Le Gouill, MD PhD, Ghandi Damaj, MD
Journal: Blood
Blood (2014) 124 (21): 148.
https://doi.org/10.1182/blood.V124.21.148.148
Published: 2014
Journal Articles

The Ribvd Regimen (Rituximab IV, Bendamustine IV, Velcade SC, Dexamethasone IV) Offers a High Complete Response Rate In Elderly Patients With Untreated Mantle Cell Lymphoma. Preliminary Results Of The Lysa Trial “Lymphome Du Manteau 2010 SA”

Remy Gressin, MD, Mary Callanan, MD, PhD, Nicolas Daguindau, MD, Adrian Tempescul, MD, Sylvain Carras, Guillaume Cartron, MD, PhD, Anne Schmitt, MD, Roch Houot, MD, PhD, Caroline Dartigeas, MD, Jean Michel Pignon, MD, Selim Corm, MD, PhD, Anne Banos, MD, Jehan Dupuis, MD, Christiane Mounier, MD, Margareth Macro, MD, Joel Fleury, MD, Fabrice Jardin, MD, PhD, Lionel Kardin, MD, Gandhi Damaj, MD, Pierre Feugier, MD, PhD, luc Matthieu Fornacker, MD, Cecile molucon Chabrot, MD, Veronique Dorvaux, MD, Krimo Bouabdallah, MD, Sandy Amorin, MD, Reda Garidi, MD, Laurent Voillat, MD, Bertrand Joly, MD, Philippe Solal-Céligny, MD, Nadine Morineau, MD, Marie Pierre Moles, MD, Hacene Zerazhi, MD, Jean Fontan, MD, Yazid Arkam, MD, Magda Alexis, MD, Vincent Delwail, MD, Jean Pierre Vilque, MD, Loic Ysebaert, MD PhD, Steven Le Gouill, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 370.
https://doi.org/10.1182/blood.V122.21.370.370
Published: 2013
Journal Articles

Coexistance of Multiple Myeloma and Myelodysplastic Syndrome or Lymphoid Diseases At Diagnosis: Evidence for Two Clonal and Independent Chromose Abnormalities

Hossein Mossafa, PhD, Sabine Defasque, Jr., MD, Christine Fourcade, Sr., JeanPierre Hurst, Sr., Bertrand Joly
Journal: Blood
Blood (2011) 118 (21): 5063.
https://doi.org/10.1182/blood.V118.21.5063.5063
Published: 2011
Journal Articles

Molecular predictors of response to decitabine in advanced chronic myelomonocytic leukemia: a phase 2 trial

Clinical Trials & Observations
Thorsten Braun, Raphael Itzykson, Aline Renneville, Benoit de Renzis, François Dreyfus, Kamel Laribi, Krimo Bouabdallah, Norbert Vey, Andrea Toma, Christian Recher, Bruno Royer, Bertrand Joly, Anne Vekhoff, Ingrid Lafon, Laurence Sanhes, Guillaume Meurice, Cédric Oréar, Claude Preudhomme, Claude Gardin, Lionel Ades, Michaela Fontenay, Pierre Fenaux, Nathalie Droin, Eric Solary, on behalf of the Groupe Francophone des Myélodysplasies
Journal: Blood
Blood (2011) 118 (14): 3824–3831.
https://doi.org/10.1182/blood-2011-05-352039
Published: 2011
Includes: Supplemental data
Journal Articles

A Phase II Study of Decitabine In Advanced Chronic Myelomonocytic Leukemia (CMML)

Thorsten Braun, Nathalie Droin, Benoit de Renzis, Francois Dreyfus, Kamel Laribi, Krimo Bouabdallah, Aude Charbonnier, Catherine Cordonnier, Ingrid Lafon, Christian Récher, Norbert Vey, Jean-Noel M. Bastie, A. Besancon, Odile Beyne-Rauzy, Bertrand Joly, Eric Jourdan, Laurence Legros, Zora Marjanovic, Charlotte Petitdidier, Bruno Royer, Laurence Sanhes, Gerard Tertian, Ioana Vaida, Xavier Vallantin, Anne Vekhoff, Marina Milic, Raphael Itzykson, Claude Gardin, Lionel Ades, Pierre Fenaux, Eric Solary
Journal: Blood
Blood (2010) 116 (21): 1873.
https://doi.org/10.1182/blood.V116.21.1873.1873
Published: 2010
Journal Articles

High Frequency of Marginal Zone Lymphomas Among Patients Coinfected with Human Immunodeficiency Virus and Hepatitis C Virus - ANRS CO16 LYMPHOVIR Cohort Study

Benjamin Terrier, Dominique Costagliola, Houria Chavez, Danielle Canioni, MD, Régis Costello, Lilia Escaut, Bertrand Joly, Lorraine Le Tranchant, Pascale Morineau-Le Houssine, Anne Simon, Yassine Taoufik, Sophie Prevot, Patrice Cacoub, Martine Raphael, MD, PhD, Caroline Besson
Journal: Blood
Blood (2010) 116 (21): 4156.
https://doi.org/10.1182/blood.V116.21.4156.4156
Published: 2010
Journal Articles

Partial Efficacy of Bortezomib on Acute Myeloid Leukemia (AML) Cells in a Patient with Concomitant Multiple Myeloma and AML.

Bertrand Joly, Patrick Quillet, Celia Salanoubat, Selwa Bouledroua, Charlotte Petitdidier, Alain Devidas
Journal: Blood
Blood (2007) 110 (11): 4379.
https://doi.org/10.1182/blood.V110.11.4379.4379
Published: 2007
Journal Articles

Rituximab in Combination with CHOP Regimen in Angioimmunoblastic T-Cell Lymphoma (AITL). Preliminary Results in 9 Patients Treated in a Single Institution.

Bertrand Joly, Valerie Frenkel, Philippe Gaulard, Karim Belhadj, Taoufik El Gnaoui, Jehan Dupuis, Marine Divine, Alain Rahmouni, Christiane Copie Bergman, Marie Helene Delfau-Larue, Felix Reyes, Corinne Haioun
Journal: Blood
Blood (2005) 106 (11): 2686.
https://doi.org/10.1182/blood.V106.11.2686.2686
Published: 2005
Journal Articles

Rituximab, Gemcitabine and Oxaliplatin (R-GEMOX): A Promising Regimen for Refractory/Relapsed B-Cell Lymphoma.

Taoufik El Gnaoui, Jehan Dupuis, Bertrand Joly, Karim Belhadj, Alain Rahmouni, Christiane Copie-Bergman, Antoine Allain, Isabelle Tabah-Fish, Felix Reyes, Corinne Haioun
Journal: Blood
Blood (2004) 104 (11): 2483.
https://doi.org/10.1182/blood.V104.11.2483.2483
Published: 2004
Journal Articles

Delayed Severe Neutropenia after Rituximab Therapy in 18 among 293 Patients with B-Cell Malignancies Treated in a Single Institution. an Adverse Event of Unknown Mechanism.

Karim Belhadj, Taoufik El Gnaoui, Kamal Doghmi, Bertrand Joly, Ketty Lee, Anne Plonquet, Hélène Jouault, Karine Gourlain, Marie-Hélène Delfau-Larue, Chantal André, Felix Reyes, Corinne Haioun
Journal: Blood
Blood (2004) 104 (11): 1326.
https://doi.org/10.1182/blood.V104.11.1326.1326
Published: 2004